Review Article

Pharmacogenomics and Opioid Analgesics: Clinical Implications

Table 3

Prospective studies providing evidence on the impact of polymorphisms of CYP2D6 on the analgesic efficacy of tramadol.

AuthorPolymorphismEffect

Stamer et al., 2003 [34]CYP2D61, 3, 4, 5, 9, 10, CYP2D617, CYP2D61 × NPoor metabolizers for CYP2D6 showed a lower response rate to tramadol analgesia for postoperative pain after abdominal surgery

Wang et al., 2006 [37]CYP2D610 C188TThis SNP reduced tramadol analgesic efficacy in a Chinese patients treated for postoperative pain after major abdominal surgery

Siew et al., 2007 [35]CYP2D61, 3, 4, 5, 9, 10, CYP2D617, CYP2D61 × NThe analgesic effects of tramadol were not measured adequately. Therefore the effect of genotype on tramadol analgesic efficacy was not demonstrated

Slanar et al., 2012 [36]CYP2D63, CYP2D64, CYP2D65, CYP2D66
CYP2D61 × N
CYP2D6 genotype did not affect tramadol analgesic efficacy in postoperative patients after knee arthroplasty